Family Medicine · Glendale, CA
NPI
1841248309
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
814 E Broadway, Suite 1
Glendale, CA, 91205
Phone (818) 265-5040
Groups this clinician bills Medicare through
Medicare paid, 2024
$874K
12,882 services
Medicare patients, 2024
1,088
Average age 77
Drug cost, 2024
$6.0M
49,523 prescriptions
Company payments, 2025
$13K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Narine Arutyounian was code 99233 (hospital e&m - subsequent), 3,442 times for 515 patients. In total Narine Arutyounian billed 12,882 services in 51 codes, and Medicare paid $874K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 3,442 | 515 | $91.94 | $316K |
| 99214 Office E&M - Established | Office | 1,442 | 500 | $101.24 | $146K |
| 36415 Venipuncture Blood Collection | Office | 1,084 | 473 | $8.65 | $9,377 |
| 82962 Clinical Chemistry | Office | 960 | 229 | $3.21 | $3,082 |
| 99213 Office E&M - Established | Office | 864 | 402 | $72.16 | $62K |
| 99239 Hospital Discharge Management | Facility | 569 | 412 | $89.77 | $51K |
| 99223 Hospital E&M - Initial | Facility | 560 | 428 | $134.07 | $75K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 409 | 409 | $19.88 | $8,132 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 408 | 408 | $19.88 | $8,112 |
| 99497 Care Management/Coordination | Office | 399 | 398 | $81.23 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 378 | 117 | $61.10 | $23K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 357 | 357 | $132.27 | $47K |
| 99222 Hospital E&M - Initial | Facility | 183 | 163 | $101.19 | $19K |
| 99291 Critical Care E&M | Facility | 165 | 51 | $163.05 | $27K |
| 93000 Electrocardiogram | Office | 152 | 131 | $11.48 | $1,745 |
By year: 2022 $709K for 9,668 services; 2023 $802K for 10,782 services; 2024 $874K for 12,882 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,084 | 473 | $8.65 | $9,377 |
| 82962 Clinical Chemistry | 960 | 229 | $3.21 | $3,082 |
| 81002 Clinical Chemistry | 46 | 43 | $3.41 | $157 |
Medicare prescription drug claims, 2024
In 2024, the drug Narine Arutyounian prescribed most often to Medicare patients was Gabapentin, with 1,933 prescriptions and refills. In total Narine Arutyounian wrote 49,523 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,933 | 2,101 | 255 | $5,078 |
| Rosuvastatin Calcium Generic | 1,830 | 2,051 | 229 | $6,385 |
| Levothyroxine Sodium Generic | 1,457 | 1,598 | 158 | $5,347 |
| Vascepa Icosapent Ethyl | 1,367 | 1,421 | 206 | $393K |
| Metformin Hcl Generic | 1,312 | 1,455 | 163 | $129K |
| Allopurinol Generic | 1,257 | 1,375 | 160 | $3,620 |
| Icosapent Ethyl Generic | 1,174 | 1,251 | 230 | $183K |
| Amlodipine Besylate Generic | 1,131 | 1,287 | 166 | $1,219 |
| Atorvastatin Calcium Generic | 1,123 | 1,312 | 162 | $3,004 |
| Escitalopram Oxalate Generic | 1,066 | 1,163 | 146 | $2,537 |
| Carvedilol Generic | 1,021 | 1,134 | 132 | $1,970 |
| Montelukast Sodium Generic | 915 | 969 | 118 | $3,120 |
| Tamsulosin Hcl Generic | 841 | 944 | 120 | $4,040 |
| Omeprazole Generic | 827 | 900 | 106 | $2,028 |
| Potassium Chloride Generic | 822 | 885 | 105 | $5,580 |
Brand drugs: 8,090 claims; generic drugs: 40,704 claims; opioid claims: 230.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Narine Arutyounian $13K ($13K in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $9,857.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 24 | $9,857 |
| Abbvie Inc. ABBV | 5 | $1,998 |
| Ardelyx, Inc. ARDX | 6 | $157 |
| Novo Nordisk Inc NVO | 5 | $119 |
| Pfizer Inc. PFE | 4 | $99.13 |
| GlaxoSmithKline, LLC. GSK | 3 | $73.59 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $66.15 |
| Vivus LLC | 2 | $38.92 |
| Lilly USA, LLC LLY | 2 | $31.39 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $29.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.